- Location
renal denervation
"-
Medtronic Is Back at Renal Denervation
Apr 3, 2015Symplicity Spyral Multi-electrode Renal Denervation Catheter (Image courtesy of Medtronic) The medtech giant isn’t giving up yet on renal denervation, if a new announcement is any indication. Chris Newmarker Medtronic is ...
Tags: Medtronic, Chris Newmarker, Medicine
-
Recor Medical Announces Major Advances in Its Paradise System for Renal Denervation
Feb 7, 2014ReCor Medical has announced major advances in its Paradise System for renal denervation (RDN), confirming its commitment to lead in the treatment of patients with resistant hypertension (HTN). The company announced that it has received ...
Tags: renal denervation system, health, HTN
-
Renal Denervation as a High Blood Pressure Treatment Is Looking Less Exciting by The Day
Jan 23, 2014Renal denervation as a high blood pressure treatment is looking less exciting by the day, with the latest bad news coming from Covidien. The Dublin, Ireland–based medical device giant said Tuesday that it will exit its OneShot renal ...
-
Medtronic's Symplicity System Failed on Efficacy in a Pivotal U.S. Clinical Trial.
Jan 16, 2014Posted in Cardiovascular by Chris Newmarker on January 15, 2014 Boston Scientific CEO Mike Mahoney remains optimistic about renal denervation and the company’s Vessix platform, even though Medtronic’s Symplicity system failed ...
Tags: Boston Scientific, Mike Mahoney, renal denervation, Vessix platform
-
Medtronic Willfully Infringed on an Edwards Lifesciences' Patent
Jan 16, 2014Medtronic willfully infringed on an Edwards Lifesciences’ patent with its CoreValve transcatheter heart valve, and owes Edwards nearly $394 million in damages and patent royalties, a federal jury in Delaware found Wednesday. Edwards ...
Tags: Medtronic, CoreValve, transcatheter heart valve, Edwards
-
Creganna-Tactx Medical Will Showcase The Expertise of Its CaliforniaCenter of Excellence
Dec 20, 2013Creganna-Tactx Medical, a global Top 10 provider of medical device outsourcing solutions, will showcase the expertise of its CaliforniaCenter of Excellence for Emerging Therapies at the Transcatheter Cardiovascular Therapeutics (TCT) ...
Tags: medical device
-
Randomization of First Patients in Symplicity HTN-4 Trial is declared by Medtronic
Dec 19, 2013US-based medical technology company Medtronic has announced the randomization of the first patients in the SYMPLICITY HTN-4 clinical trial at Medical University of South Carolina, Piedmont Heart Institute and Duke University Medical Center. ...
-
CE Mark Approval for Symplicity Spyral Catheter Is Announced by Medtronic
Dec 9, 2013Medtronic, a medical technology company, has announced CE Mark approval in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its Symplicity Spyral catheter and Symplicity G3 radio frequency (RF) generator. ...
Tags: Medtronic, medical technology
-
Medtronic Obtained a Device Exemption From FDA to Initiate Symplicity Htn-4 Clinical Trial
Nov 7, 2013Medtronic has obtained an investigational device exemption from the US Food and Drug Administration (FDA) to initiate SYMPLICITY HTN-4 clinical trial using its Symplicity renal denervation system. SYMPLICITY HTN-4 study has been designed ...
-
Cardiosonic Announced It Is Currently Enrolling Patients in The TIVUS II Clinical Trial
Oct 21, 2013Israel-based Cardiosonic announced it is currently enrolling patients in the TIVUS II clinical trial, designed to assess the safety, efficacy and performance of its TIVUS system using a next generation multidirectional catheter. TIVUS ...
Tags: Cardiosonic, Clinical Trial
-
Preliminary Data From Global Symplicity Registry Is Unveiled by Medtronic
Sep 4, 2013Medtronic has unveiled new data from the Global SYMPLICITY Registry, a multi-centre, prospective, observational registry designed to collect comprehensive data evaluating procedural and long-term safety of the Symplicity renal denervation ...
Tags: Medtronic, Symplicity Registry
-
St Jude Medical Asserted That EnligHTN Renal Denervation Technology Reduces Blood Pressure
May 24, 2013St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
-
Medtronic Has Completed Randomizing Symplicity HTN-3
May 24, 2013Medtronic has completed randomizing Symplicity HTN-3, a clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure that decreases the ...
Tags: Medtronic, Randomizing Symplicity
-
St Jude Medical Has Commenced Its Enlightnment Clinical Study
May 23, 2013US-based medical device company St Jude Medical has commenced its EnligHTNment clinical study. The EnligHTNment study will assess whether the EnligHTN Multi-Electrode Renal Denervation System can minimize the risk of major cardiovascular ...
Tags: St Jude Medical, Clinical Study
-
St. Jude Medical Has Enrolled The First Patient for The Enlightn III Trial
May 16, 2013St. Jude Medical, a US-based medical device company, has enrolled the first patient for the EnligHTN III trial. During the study, the safety and performance of the second-generation EnligHTN Renal Denervation System in patients with ...